Variability in uptake efficiency for pulsed versus constant concentration delivery of inhaled nitric oxide
© Martin et al.; licensee BioMed Central Ltd. 2014
Received: 26 November 2013
Accepted: 16 January 2014
Published: 22 January 2014
Nitric oxide (NO) is currently administered using devices that maintain constant inspired NO concentrations. Alternatively, devices that deliver a pulse of NO during the early phase of inspiration may have use in optimizing NO dosing efficiency and in extending application of NO to long-term use by ambulatory, spontaneously breathing patients. The extent to which the amount of NO delivered for a given pulse sequence determines alveolar concentrations and uptake, and the extent to which this relationship varies with breathing pattern, physiological, and pathophysiological parameters, warrants investigation.
A mathematical model was used to analyze inhaled nitric oxide (NO) transport through the conducting airways, and to predict uptake from the alveolar region of the lung. Pulsed delivery was compared with delivery of a constant concentration of NO in the inhaled gas.
Pulsed delivery was predicted to offer significant improvement in uptake efficiency compared with constant concentration delivery. Uptake from the alveolar region depended on pulse timing, tidal volume, respiratory rate, lung and dead space volume, and the diffusing capacity of the lung for NO (DLNO). It was predicted that variation in uptake efficiency with breathing pattern can be limited using a pulse time of less than 100 ms, with a delay of less than 50 ms between the onset of inhalation and pulse delivery. Nonlinear variation in uptake efficiency with DLNO was predicted, with uptake efficiency falling off sharply as DLNO decreased below ~50-60 ml/min/mm Hg. Gas mixing in the conducting airways played an important role in determining uptake, such that consideration of bulk convection alone would lead to errors in assessing efficiency of pulsed delivery systems.
Pulsed NO delivery improves uptake efficiency compared with constant concentration delivery. Optimization of pulse timing is critical in limiting intra- and inter-subject variability in dosing.
Inhaled nitric oxide (NO) has been shown to act as a selective pulmonary vasodilator [1, 2]. Since this discovery more than 20 years ago, use of NO has become widespread for treating persistent pulmonary hypertension of the newborn (PPHN) , improving oxygenation in adult patients with acute lung injury or the acute respiratory distress syndrome , and in alleviating pulmonary hypertension in adults and children following cardiac surgery [5, 6]. These settings generally require NO to be delivered to mechanically ventilated patients. To do so, delivery devices have been developed which administer NO from a source cylinder containing 100–1000 ppm NO (800 ppm NO in North America) in balance nitrogen, to the inspiratory limb of the patient breathing circuit. The flow rate of NO injection is adjusted in proportion to the flow of air/oxygen in the circuit so as to produce a constant NO concentration in the inspired gas [7, 8]. Accordingly, dosing recommendations for inhaled NO have been established based on the NO concentration in inspired gas [4, 9].
For some time, researchers have speculated that the dose–response relationship for inhaled NO might be better described in terms of alveolar concentration or uptake from the lungs, rather than inhaled concentration [10, 11]. Such considerations have often been made in the context of pulsed NO delivery systems, which deliver a predetermined volume of NO in the early portion of inhalation, with the goal of maximizing delivery to the peripheral, gas exchange lung regions, while avoiding delivery of NO to the anatomical dead space near the end of inhalation [11–15]. Pulsed systems may have use in optimizing dosing and minimizing total NO usage for intubated, ventilated patients, but also in extending application of NO to long-term use by ambulatory, spontaneously breathing patients. However, these systems are inherently poorly described using the established dose metric of inhaled NO concentration, as the concentration is intentionally varied over each inhalation. Instead, they are potentially well adapted for dosing in terms of the absolute amount (volume, mass, moles) of NO delivered per breath or over a given time period. The extent to which the amount of NO delivered for a given pulse sequence determines alveolar concentrations and uptake, and the extent to which this relationship varies with breathing pattern, and with physiological and pathophysiological parameters, is presently unclear, and thus warrants study.
This article describes a mathematical model developed to couple gas mixing and transport through the conducting airways with uptake from the alveolar lung region. Continuous or pulsed NO delivered to the extrathoracic airway was transported through serial airway generations by a combination of bulk convection and axial dispersion. Uptake from the alveolar region was determined as a function of alveolar volume and NO concentration, as well as the diffusing capacity of the lung for NO. The model was used to evaluate equivalency, in terms of alveolar concentration and uptake, between constant concentration and pulsed NO dosing, and to establish framework recommendations on pulse volume, duration, and delay time (between onset of inhalation and pulse delivery) for optimal uptake efficiency. In addition, the significance of axial dispersion on NO transport, and ultimately uptake, was evaluated, as was the sensitivity of uptake efficiency to the lung’s diffusing capacity for NO.
A single compartment, single path lung model was employed. The lung was divided into a gas-conducting region and an alveolar region. It was assumed that zero uptake of NO occurred across the conducting airways, whereas uptake from the alveolar region into the capillaries was modeled with a single transfer factor specifying volume uptake per unit time per unit partial pressure (i.e., DLNO – the diffusing capacity of the lung for NO). Inputs to the model included the DLNO, along with the functional residual capacity (FRC) of the lung, the dimensions of the conducting airways, the breathing pattern (inhaled and exhaled volumetric flow rates vs. time), and the variation in inhaled NO concentration specified over time. Outputs of the model included the time-varying concentrations of NO in each generation of the conducting airways and in the alveolar region, the rate at which NO was taken up into the capillaries, and the NO concentration in the exhaled gas.
Conducting airway dimensions from Finlay et al.
Proximal to the trachea, an extrathoracic airway was defined by a characteristic diameter and length of 0.75 cm and 30 cm, respectively, to represent an adult endotracheal tube.
where A is the total cross-sectional area of airways in the lung at a given depth x, is the NO concentration averaged over the area A, is the average flow velocity in the x-direction over the area A, and D m is the molecular diffusivity of NO in air.
where D c-d represents the contribution of convective-diffusive dispersion to the total effective diffusive flux.
where α is an empirical constant equal to 1.08 during inhalation and 0.37 during exhalation, and d is the diameter of the airway.
where f(t) specifies the inhaled NO concentration over time, and x = L denotes the boundary between conducting airways and alveolar region.
and where Q is the instantaneous volumetric flow rate of gas into or out of the lungs, V alv is the volume of the alveolar region, c alv and represent the NO concentrations in the alveolar region and in the terminal bronchioles (generation 14), respectively, and D L NO is the diffusing capacity of the lung for NO. DLNO is normally specified as the volume uptake of NO per unit time per unit partial pressure, but as written in equations (7) and (8) DLNO must be expressed in units of the quantity of NO conserved (i.e., mass, moles, or volume at STP) per unit time per unit concentration.
where C i t is the NO concentration in the ith division at time t, and l i is the length of the ith division. The parameters and D eff,i t were known, and prescribed at the start of the procedure based on the specified breathing pattern and airway dimensions.
Concentrations throughout the respiratory tract were calculated explicitly over time via the Euler method. To assess time step and spatial grid size dependence, initial calculations were performed with 1000, 2500, 5000, or 10000 equal time steps per breath, and for 1, 2, 3, or 5 equal length divisions per generation. For constant inhaled NO concentrations, increasing the number of time steps per breath or divisions per generation had negligible effect on NO uptake and uptake efficiency, save that in the case of 5 divisions per generation 5000 time steps per breath were required for convergence. For calculations performed for pulsed NO delivery, increasing the number of divisions per generation from 1 to 3 reduced NO uptake and uptake efficiency slightly, while further increase above 3 divisions had negligible effect. Effects of time step size were negligible, save that again 5000 time steps per breath were required for convergence in the case of 5 divisions per generation. For all combinations of time step and divisions, convergence or divergence of the solution was well predicted by applying the practical criterion given by Darquenne and Paiva  at the terminal conducting airway (generation 14 in the present model). Results presented below were obtained using 5 divisions per generation and 5000 time steps per breath.
Subsequent calculations were performed using the present model to simulate constant and pulsed delivery of NO to adult humans. A base parameter set was defined with FRC of 3000 ml, DLNO of 150 ml/min/mm Hg, tidal volume of 500 ml, breath frequency of 12 min-1, inspiratory time fraction of 1/3, and expiratory time constant of 0.6 s. Individual parameters were varied to explore their effects on NO uptake and uptake efficiency. The breathing pattern took the form shown in Figure 2, with constant inhalation flow and an exponentially-decaying exhalation flow. The coefficient A defining the peak expiratory flow was calculated for a given inhaled tidal volume, expiratory time constant, and expiratory time so as to set the exhaled tidal volume equal to the inhaled tidal volume.
Proportional delivery was modeled using a constant 20 ppm inhaled concentration of NO. Three different pulse durations, tpulse, were studied: 100, 200, and 400 ms. Pulses were modeled as square waves as depicted in Figure 2. Each pulse delivered 8 μg NO/breath (equivalent to 267 nmol NO/breath). This dose was chosen based on initial calculations performed using the model so as to yield equivalent alveolar NO concentration and uptake for the base parameter set as the constant 20 ppm delivery case. For t pulse of 100, 200, and 400 ms, 800 ppm NO in balance N2 was introduced at 75, 37.5 and 18.75 mL/s, respectively. Again, the NO/N2 stream was assumed to be well mixed with the inhaled air stream at the entrance to the extrathoracic region. The effect of delay between the start of inspiration and pulse delivery was studied by setting a pulse delay, t pulse delay , of 0, 50, 100, 200 ms.
Comparison of nitric oxide concentrations and uptake efficiencies in intubated, mechanically ventilated pigs
FANO, end tidal
FENO, end tidal
5 ppm constant
100 nmol/min pulsed
Heinonen et al.model:
5 ppm constant
100 nmol/min pulsed
Heinonen et al.data*:
5 ppm constant
100 nmol/min pulsed
Constant concentration versus pulsed dosing
Effects of pulse delay
Effects of pulse time and pulse delay on nitric oxide uptake efficiency for varied breathing patterns
Vt = 500 ml
Vt = 500 ml
Vt = 250 ml
Vt = 250 ml
f = 12 min-1
f = 25 min-1
f = 12 min-1
f = 25 min-1
Uptake efficiency versus DLNO
Uptake of NO from the alveolar region depended on pulse timing, tidal volume, respiratory rate, lung and dead space volume, and the diffusing capacity of the lung for NO (DLNO). In general, uptake efficiency was consistently higher for pulsed NO delivery than for constant concentration delivery. As will be discussed below, pulse time and delay influenced uptake efficiency more significantly as breath frequency increased, and as tidal volume decreased. In these circumstances, gas mixing in the conducting airways played an important role in determining uptake efficiency for pulsed delivery.
In order to verify calculations made using the model presented above, predictions of alveolar and exhaled NO concentrations, and NO uptake efficiency, were compared with those made previously by Heinonen et al.. Those authors constructed a model simulating bulk convection through a single channel, representing the conducting airways, supplying an elastic compartment, representing the alveolar region, and found good agreement with peak and end-tidal exhaled NO concentration measured during pulsed and constant concentration NO delivery to intubated, mechanically ventilated pigs. As seen in Table 2, predictions made using the present model were in close agreement with those made by Heinonen et al.. The agreement between these two distinct models, and their consistency with in vivo data from an animal model, provides a measure of confidence in moving forward to make predictions regarding NO delivery to humans.
Constant concentration versus pulsed dosing
One practical application of the model presented here is to guide the design of pulsed NO dosing systems. A logical starting point is to tune pulse volume and timing so as to produce equivalent alveolar concentration and uptake as predicted for delivery of a given constant NO concentration, where dose–response relationships are more established. This was the approach adopted in selecting the 8 μg NO/breath pulses studied herein. As shown in Figure 4, for the base set of input parameters, variation in alveolar concentration over time is very similar for the three pulsed delivery modes as for constant delivery of 20 ppm inhaled NO. NO uptake was also nearly identical between the pulsed and constant modes. Each input parameter was then varied independently to assess its influence on NO uptake, and results are presented in Figure 5. The same calculations are presented in terms of uptake efficiency in Figure 6. With the exception of respiratory rate, variation of NO uptake is predicted to be less influenced by input parameter variation for pulsed than for constant dosing. In particular, NO uptake for pulsed delivery is predicted to be relatively insensitive to tidal volume and FRC, except when tidal volume becomes small or FRC large, in which cases uptake is seen to decrease. Noting that conducting airway volume scaled with FRC, the latter effect arises due to incomplete transport of NO through the conducting airways during inhalation, such that an increasing fraction of NO is exhaled. When tidal volume was allowed to increase in proportion with FRC, as in Figures 5f and 6f, NO uptake and uptake efficiency remained constant for pulsed dosing as FRC varied.
Of note, uptake efficiency was predicted to remain significantly greater for pulsed dosing than for constant dosing in all cases presented in Figure 6. This is seen as an advantage of pulsed delivery systems, in that less NO may be required to maintain an equivalent therapeutic effect. A potential further advantage of pulsed dosing systems is to improve correlation between NO dose and patient response. Under the assumption that therapeutic effects are closely related to uptake, uptake efficiency would ideally remain near 1.0, or at least remain constant, such that the rate of NO uptake could be closely estimated based on the rate of NO delivery. This would allow dosing to be performed through monitoring the absolute amount (mass, volume, moles) of NO delivered, with the potential to improve dose–response correlations [10, 11].
Effects of pulse delay
While uptake efficiency remained near 1.0 for the majority of the parameter range presented in Figure 6, the case of low tidal volume was further examined, as reported in Table 3. Here, the delay time between onset of inhalation and pulse delivery was also considered. At a resting breathing pattern with tidal volume of 500 ml and breathing frequency of 12 min-1, uptake efficiency remained above 0.9 even for the extreme case of a 400 ms pulse, with 200 ms delay. In contrast, for rapid, shallow breathing with tidal volume of 250 ml and breathing frequency of 25 min-1, uptake efficiency was lower, and much more sensitive to both pulse time and delay. In order to minimize these effects, a pulse time of 100 ms or less, with delay less than 50 ms, is desirable. Making a comparison with pulsed oxygen delivery devices, as have previously been adapted for ambulatory NO delivery through nasal cannulae [12, 13], a 50 ms delay is within the range of values reported for commercially available devices . In turn, a pulse time of 100 ms is near reported values for the lowest pulse setting on the majority of devices . Given that required pulse volumes for high concentration NO source gas will generally be smaller than for oxygen, pulse times at or below 100 ms are technically feasible.
Uptake efficiency versus DLNO
All results discussed above were obtained from calculations in which the DLNO was fixed at 150 ml/min/mm Hg. This falls approximately in the middle of the range reported by Zavorsky et al. for healthy adults performing single-breath-hold maneuvers at rest. Significant variation between subjects is expected even in healthy populations, and certainly in patients with respiratory or cardiovascular disease. For example, in patients with pulmonary arterial hypertension (PAH), average DLNO values have been reported as approximately 60–80 ml/min/mm Hg [25, 26], with values below 50 ml/min/mm Hg reported in individual patients . Figure 7 demonstrates considerable sensitivity of uptake efficiency to DLNO within lower ranges, especially for pulsed delivery. In contrast, at higher ranges, uptake efficiency was much less sensitive to DLNO, indicative of excess capacity to take up NO at typical therapeutic dose levels in lungs which maintain normal, or near-normal, alveolar membrane conductance. It is interesting to comment that even for the most efficient case studied, 100 ms pulse with zero delay, uptake efficiency is predicted to lie between approximately 0.7 and 0.9 for DLNO values typical of PAH patients. This presents an apparent discrepancy with clinical experience delivering pulsed NO to PAH patients, where no detectable exhaled NO has been reported [13, 15], suggesting an uptake efficiency near 1.0. It may be that exhaled NO concentrations in clinical evaluations were simply below the detection limit of the analyzers employed (peak exhaled NO would likely not exceed 1 or 2 ppm, and last fractions of a second, while end-tidal values would lie well below 1 ppm).
Based on present understanding, it appears that the amount of NO delivered is not directly predictive of the amount of NO uptake, such that monitoring NO delivery alone cannot be considered a substitute for monitoring uptake. As variation in uptake efficiency is more pronounced at low DLNO, considerable dose titration may be required for patients with initially low DLNO that receive NO therapy. This is true for both pulsed dosing and constant concentration dosing. In relative terms, pulsed dosing offered considerable improvement in uptake efficiency compared with constant concentration dosing even for the lowest DLNO values studied.
Nitrogen dioxide production
It may be noted that reaction between NO and oxygen to produce nitrogen dioxide (NO2) has not been included in the present model description. In fact, a version of the model was built to include such effects, but NO2 production was extremely small. This can be deduced from back of the envelope calculations, given that the chemical kinetics and rate of reaction between NO and oxygen are well known . For example, at a representative inhalation flow rate of 300 ml/s, the residence time of gases passing through the conducting airways is less than 1 s. For 20 ppm NO reacting with 100% oxygen, less than 10 parts per billion (ppb) NO2 are produced per second. While initial NO concentrations are higher for pulsed delivery, dispersion is rapid (Figure 3b) such that these higher concentrations are very short lived. In the alveolar region, NO concentrations are much lower: assuming an alveolar NO concentration maintained at 1 ppm through supply from the conducting airways, the time to produce 1 ppm NO2, even in 100% oxygen, is more than 10 hours – and this assumes NO2 accumulates in the alveolar region with no uptake. While such conditions may be possible during extended NO delivery to patients with poorly ventilated and poorly perfused lung regions, the risk of NO2 production in the lungs is small in comparison with the risk of NO2 developing in breathing circuits used to convey gases to the patient. In the latter case, the combination of sufficiently large NO concentrations and residence times to produce appreciable amounts of NO2 may exist, and precautions to avoid excess NO2 production have been documented [10, 28].
Conducting airways model
Several limitations of the present model present opportunities for future work. First, extension to multiple paths and multiple compartments would allow the interplay between regional variation of respiratory mechanics, ventilation, perfusion, and uptake efficiency to be explored. Second, the possibility of significant concentration gradients within the alveolar air spaces could be explored by moving to a multi-generation model of the alveolar region [31, 32], with potential impact on total uptake efficiency. Finally, the present model treated the extrathoracic airway as a single tube, representative of an endotracheal tube, while pulsed delivery has frequently been linked with long term administration of NO through nasal cannulae. Depending on the cannula design, mixing of NO source gas with room air, and with any additional supplemental oxygen, will occur during transit through the nasal air passages and will determine boundary conditions entering the trachea. More accurate representation of concentration profiles exiting the extrathoracic airway will likely require bench experiments, or computational fluid dynamics simulations, specific to a given patient interface and nasal airway geometry.
In conclusion, pulsed NO delivery offers significant improvement in uptake efficiency compared with constant concentration delivery. However, uptake from the alveolar region can depend on pulse timing, tidal volume, respiratory rate, lung and dead space volume, and DLNO. It is predicted that variation in uptake efficiency with breathing pattern can be moderated using a pulse time of less than 100 ms, with a delay of less than 50 ms between the onset of inhalation and pulse delivery. Nonlinear variation in uptake efficiency with DLNO was predicted, with uptake efficiency falling off sharply as DLNO decreased below ~50-60 ml/min/mm Hg. Gas mixing in the conducting airways played an important role in determining uptake efficiency for pulsed delivery.
- Frostell C, Fratacci M, Wain J, Jones R, Zapol W: Inahled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction. Circulation. 1991, 83: 2038-2047. 10.1161/01.CIR.83.6.2038.View ArticlePubMedGoogle Scholar
- Roberts J, Polaner D, Zapol W, Lang P: Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992, 340 (8823): 818-819. 10.1016/0140-6736(92)92686-A.View ArticlePubMedGoogle Scholar
- Committee on Fetus and Newborn: Use of inhaled nitric oxide. Pediatrics. 2000, 106: 344-345.View ArticleGoogle Scholar
- Griffiths M, Evans T: Inhaled nitric oxide therapy in adults. N Engl J Med. 2005, 353: 2683-2695. 10.1056/NEJMra051884.View ArticlePubMedGoogle Scholar
- Checchia P, Bronicki R, Goldstein B: Review of inhaled nitric oxide in the pediatric cardiac surgery setting. Pediatr Cardiol. 2012, 33 (4): 493-505. 10.1007/s00246-012-0172-4.View ArticlePubMedGoogle Scholar
- OZ M, Ardehali A: Collective review: perioperative uses of inhaled nitric oxide in adults. Heart Surg Forum. 2004, 7 (6): E584-E589. 10.1532/HSF98.20041136.View ArticlePubMedGoogle Scholar
- Young J, Roberts M, Gale L: Laboratory evaluation of the I-NOvent nitric oxide delivery device. Br J Anaesth. 1997, 79: 398-401. 10.1093/bja/79.3.398.View ArticlePubMedGoogle Scholar
- Kirmse M, Hess D, Fujino Y, Kacmarek R, Hurford W: Delivery of inhaled nitric oxide using the ohmeda INOvent delivery system. Chest. 1998, 113: 1650-1657. 10.1378/chest.113.6.1650.View ArticlePubMedGoogle Scholar
- Tworetzky W, Bristow J, Moore P, Brook M, Segal M, Brasch R, Hawgood S, Fineman J: Inhaled nitric oxide in neonates with persistent pulmonary hypertension. Lancet. 2001, 357 (9250): 118-120. 10.1016/S0140-6736(00)03548-0.View ArticlePubMedGoogle Scholar
- Imanaka H, Hess D, Kirmse M, Bigatello L, Kacmarek R, Steudel W, Hurford W: Inaccuracies of nitric oxide delivery systems during adult mechanical ventilation. Anesthesiology. 1997, 86: 676-688. 10.1097/00000542-199703000-00021.View ArticlePubMedGoogle Scholar
- Heinonen E, Hogman M, Merilainen P: Theoretical and experimental comparison of constant inspired concentration and pulsed delivery in NO therapy. Intensive Care Med. 2000, 26: 1116-1123. 10.1007/s001340051326.View ArticlePubMedGoogle Scholar
- Ivy D, Griebel J, Kinsella J, Abman S: Acute hemodynamic effects of pulsed delivery of low flow nasal nitric oxide in children with pulmonary hypertension. J Pediatr. 1998, 133: 453-456. 10.1016/S0022-3476(98)70287-2.View ArticlePubMedGoogle Scholar
- Channick R, Newhart J, Johnson F, Williams P, Auger W, Fedullo P, Moser K: Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension. Chest. 1996, 109: 1545-1549. 10.1378/chest.109.6.1545.View ArticlePubMedGoogle Scholar
- Katayama Y, Higenbottam T, Akamine CGS, Demoncheaux E, Smith A, Siddons T: Minimizing the inhaled dose of NO with breath-by-breath delivery of spikes of concentrated gas. Circulation. 1998, 98: 2429-2432. 10.1161/01.CIR.98.22.2429.View ArticlePubMedGoogle Scholar
- Barst R, Channick R, Ivy D, Goldstein B: Clinical perspectives with long-term pulsed inhaled nitric oxide for the treatment of pulmonary arterial hypertension. Pulmonary Circulation. 2012, 2 (2): 139-147. 10.4103/2045-8932.97589.PubMed CentralView ArticlePubMedGoogle Scholar
- Finlay W, Lange C, King M, Speert D: Lung delivery of aerosolized dextran. Am J Respir Crit Care Med. 2000, 161: 97-107.Google Scholar
- Phillips C, Kaye S, Schroter R: A diameter-based reconstruction of the branching pattern of the human bronchial tree. Respir Physiol. 1994, 98: 193-217. 10.1016/0034-5687(94)00042-5.View ArticlePubMedGoogle Scholar
- Finlay W: The Mechanics of Inhaled Pharmaceutical Aerosols. 2001, London: Academic PressGoogle Scholar
- Ben Jebria A: Convective gas mixing in the airways of the human lung - comparison of laminar and turbulent dispersion. Trans Biomed Eng. 1984, BME-31 (7): 498-506.View ArticleGoogle Scholar
- Taylor G: Dispersion of soluble matter in solvent flowing slowly through a tube. Proc R Soc. 1953, 219A: 186-203.View ArticleGoogle Scholar
- Scherer P, Shendalman L, Greene N, Bouhuys A: Measurement of axial diffusivities in a model of the bronchial airways. J Appl Physiol. 1975, 38: 719-723.PubMedGoogle Scholar
- Darquenne C, Paiva M: One-dimensional simulation of aerosol transport and deposition in the human lung. J Appl Physiol. 1994, 77 (6): 2889-2898.PubMedGoogle Scholar
- Chatburn R, Williams T: Performance comparison of 4 portable oxygen concentrators. Respir Care. 2010, 55 (4): 433-442.PubMedGoogle Scholar
- Zavorsky G, Cao J, Murias J: Reference values of pulmonary diffusing capacity for nitric oxide in an adult population. Nitric Oxide. 2008, 18: 70-79. 10.1016/j.niox.2007.10.002.View ArticlePubMedGoogle Scholar
- van der Lee I, Zanen P, Grutters J, Snijder R, van der Bosch J: Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension. Chest. 2006, 129: 378-383. 10.1378/chest.129.2.378.View ArticlePubMedGoogle Scholar
- Farha S, Laskowski D, George D, Park M, Tang W, Dweik R, Erzurum S: Loss of alveolar membrand diffusing capacity and pulmonary capillary blood volume in pulmonary arterial hypertension. Respir Res. 2013, 14: 6-10.1186/1465-9921-14-6.PubMed CentralView ArticlePubMedGoogle Scholar
- Tsukahara H, Ishida T, Mayumi M: Gas-phase oxidation of nitric oxide: chemical kinetics and rate constant. Nitric Oxide Biol Chem. 1999, 3 (3): 191-198. 10.1006/niox.1999.0232.View ArticleGoogle Scholar
- Lovich M, Bruno N, Plant C, Wei A, Vasquez G, Johnson B, Fine D, Gilbert R: Use of ultra pure nitric oxide generated by the reduction of nitrogen dioxide to reverse pulmonary hypertension in hypoxemic swine. Nitric Oxide. 2011, 24: 204-212. 10.1016/j.niox.2011.04.006.View ArticlePubMedGoogle Scholar
- Tiep B, Christopher K, Spofford B, Goodman J, Worley P, Macy S: Pulsed nasal and transtracheal oxygen delivery. Chest. 1990, 97 (2): 364-368. 10.1378/chest.97.2.364.View ArticlePubMedGoogle Scholar
- McCoy R: Oxygen-conserving techniques and devices. Respir Care. 2000, 45 (1): 95-104.PubMedGoogle Scholar
- Tawhai M, Hunter P: Characteristic respiratory airway gas mixing using a lumped parameter model of the pulmonary acinus. Respir Physiol. 2001, 127: 241-248. 10.1016/S0034-5687(01)00238-9.View ArticlePubMedGoogle Scholar
- Foucquier A, Filoche M, Moreira A, Andrade J, Arbia G, Sapoval B: A first principles calculation of the oxygen uptake in the human pulmonary acinus at maximal exercise. Respir Physiol Neurobiol. 2013, 185: 625-638. 10.1016/j.resp.2012.10.013.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.